{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T17:21:55Z","timestamp":1786123315493,"version":"build-2736575974"},"reference-count":45,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:sec>\n                    <jats:title>BACKGROUND:<\/jats:title>\n                    <jats:p>Myocardial ischemia\/reperfusion (I\/R) injury commonly occurs in patients undergoing cardiac or noncardiac surgeries, increasing perioperative mortality risk. Although numerous endogenous mediators released during I\/R contribute to myocardial damage, their mechanisms require further elucidation. We investigated whether lysophosphatidic acid (LPA), a bioactive phospholipid, mediates myocardial I\/R injury by interacting with cardiac transient receptor potential vanilloid 1 (TRPV1).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS:<\/jats:title>\n                    <jats:p>\n                      A TRPV1\n                      <jats:sup>K710N<\/jats:sup>\n                      knock-in mouse model was generated by CRISPR\/Cas9, introducing a point mutation at K710, the known LPA-binding site on TRPV1. Langendorff perfused isolated hearts from TRPV1\n                      <jats:sup>K710N<\/jats:sup>\n                      and wild-type (WT) mice underwent global I\/R injury with or without exogenous LPA (10 \u03bcM). Myocardial infarct size, coronary effluent LDH levels, and mitochondrial ultrastructure\/function were assessed. Additionally, H9c2 cardiomyocytes were transfected with a pCMV6-entry plasmid carrying TRPV1-K710N or TRPV1-WT for mitochondrial calcium influx and cell viability assays. The V1-Cal peptide (1\u03bcM), targeting the K710 region, was applied\n                      <jats:italic toggle=\"yes\">ex vivo<\/jats:italic>\n                      and\n                      <jats:italic toggle=\"yes\">in vitro<\/jats:italic>\n                      to block LPA\u2013TRPV1 interaction.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>\n                      TRPV1\n                      <jats:sup>K710N<\/jats:sup>\n                      hearts exhibited resistance to global I\/R injury versus WT hearts, with reduced infarct size (28.3 \u00b1 2.4% vs 39.9 \u00b12.3%, respectively,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = .0006), lower LDH levels, and attenuated mitochondrial damage. Exogenous LPA exacerbated I\/R injury in WT hearts, increasing infarct size (63.7 \u00b1 1.2% vs vehicle: 38.4 \u00b1 2.4%;\n                      <jats:italic toggle=\"yes\">P &lt;<\/jats:italic>\n                      .0001), LDH release, and mitochondrial damage. TRPV1\n                      <jats:sup>K710N<\/jats:sup>\n                      hearts were resistant to LPA-induced injury, with no significant increase in infarct size after LPA treatment. Exogenous LPA induced pronounced swelling in mitochondria isolated from WT hearts, while mitochondria from TRPV1\n                      <jats:sup>K710N<\/jats:sup>\n                      hearts showed resistance to LPA challenge. In H9c2 cells, LPA significantly decreased viability in rTRPV1-WT cells and elevated mitochondrial calcium influx relative to rTRPV1-K710N cells. V1-Cal peptide attenuated LPA-mediated myocardial injury in WT hearts and reduced mitochondrial calcium overload in H9c2 cells.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS:<\/jats:title>\n                    <jats:p>Blockade of the TRPV1 K710 site by K710N mutation or V1-Cal peptide mitigates LPA-mediated myocardial injury and mitochondrial damage\/dysfunction in isolated mouse hearts. Targeting the cardiac LPA\u2013TRPV1 interaction represents a promising therapeutic strategy against perioperative myocardial injury.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1213\/ane.0000000000007907","type":"journal-article","created":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T22:00:06Z","timestamp":1768428006000},"page":"405-417","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Site-Specific Blockade of LPA\u2013TRPV1 Interaction at K710 Residue Influences on Myocardial Ischemia\/Reperfusion Injury in Ex Vivo Mouse Hearts"],"prefix":"10.1213","volume":"143","author":[{"given":"Muge","family":"Qile","sequence":"first","affiliation":[{"name":"Department of Anesthesiology and Perioperative Medicine, The Second Affiliated Hospital of Anhui Medical University, Hefei, China"},{"name":"Key Laboratory of Anesthesiology and Perioperative Medicine of Anhui Higher Education Institutes, Anhui Medical University, Hefei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaofei","family":"Luo","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Perioperative Medicine, The Second Affiliated Hospital of Anhui Medical University, Hefei, China"},{"name":"Key Laboratory of Anesthesiology and Perioperative Medicine of Anhui Higher Education Institutes, Anhui Medical University, Hefei, China"},{"name":"Department of Anesthesiology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Perioperative Medicine, The Second Affiliated Hospital of Anhui Medical University, Hefei, China"},{"name":"Key Laboratory of Anesthesiology and Perioperative Medicine of Anhui Higher Education Institutes, Anhui Medical University, Hefei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueying","family":"Cheng","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Perioperative Medicine, The Second Affiliated Hospital of Anhui Medical University, Hefei, China"},{"name":"Key Laboratory of Anesthesiology and Perioperative Medicine of Anhui Higher Education Institutes, Anhui Medical University, Hefei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Perioperative Medicine, The Second Affiliated Hospital of Anhui Medical University, Hefei, China"},{"name":"Key Laboratory of Anesthesiology and Perioperative Medicine of Anhui Higher Education Institutes, Anhui Medical University, Hefei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liu","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Perioperative Medicine, The Second Affiliated Hospital of Anhui Medical University, Hefei, China"},{"name":"Key Laboratory of Anesthesiology and Perioperative Medicine of Anhui Higher Education Institutes, Anhui Medical University, Hefei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingtong","family":"Wang","sequence":"additional","affiliation":[{"name":"Institute of Clinical Pharmacology, Key Laboratory of Anti-Inflammatory and Immune Medicine, Ministry of Education, Anhui Medical University, Hefei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Perioperative Medicine, The Second Affiliated Hospital of Anhui Medical University, Hefei, China"},{"name":"Key Laboratory of Anesthesiology and Perioperative Medicine of Anhui Higher Education Institutes, Anhui Medical University, Hefei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric R.","family":"Gross","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Perioperative and Pain Medicine, School of Medicine, Stanford University, Stanford, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shufang","family":"He","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Perioperative Medicine, The Second Affiliated Hospital of Anhui Medical University, Hefei, China"},{"name":"Key Laboratory of Anesthesiology and Perioperative Medicine of Anhui Higher Education Institutes, Anhui Medical University, Hefei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,1,14]]},"reference":[{"key":"R1-20260702","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1093\/eurheartj\/ehx383","article-title":"ESC Joint Working Groups on Cardiovascular Surgery and the Cellular Biology of the Heart Position Paper: perioperative myocardial injury and infarction in patients undergoing coronary artery bypass graft surgery.","volume":"38","author":"Thielmann","year":"2017","journal-title":"Eur Heart J"},{"key":"R2-20260702","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1001\/jama.2017.4360","article-title":"Association of postoperative high-sensitivity troponin levels with myocardial injury and 30-Day mortality among patients undergoing noncardiac surgery.","volume":"317","author":"Devereaux","year":"2017","journal-title":"JAMA"},{"key":"R3-20260702","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1093\/cvr\/cvx049","article-title":"Novel targets and future strategies for acute cardioprotection: position Paper of the European Society of Cardiology Working Group on Cellular Biology of the Heart.","volume":"113","author":"Hausenloy","year":"2017","journal-title":"Cardiovasc Res"},{"key":"R4-20260702","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jacc.2018.09.086","article-title":"Multitarget strategies to reduce myocardial ischemia\/reperfusion injury: JACC review topic of the week.","volume":"73","author":"Davidson","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"R5-20260702","doi-asserted-by":"crossref","first-page":"107404","DOI":"10.1016\/j.pharmthera.2019.107404","article-title":"Lysophosphatidic acid and its receptors: pharmacology and therapeutic potential in atherosclerosis and vascular disease.","volume":"204","author":"Zhou","year":"2019","journal-title":"Pharmacol Ther"},{"key":"R6-20260702","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1080\/00365510310003265","article-title":"Serum lysophosphatidic acid concentrations measured by dot immunogold filtration assay in patients with acute myocardial infarction.","volume":"63","author":"Chen","year":"2003","journal-title":"Scand J Clin Lab Invest"},{"key":"R7-20260702","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.yjmcc.2020.09.011","article-title":"Autotaxin inhibition reduces cardiac inflammation and mitigates adverse cardiac remodeling after myocardial infarction.","volume":"149","author":"Tripathi","year":"2020","journal-title":"J Mol Cell Cardiol"},{"key":"R8-20260702","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1161\/01.CIR.0000083715.37658.C4","article-title":"Subtype-selective antagonists of lysophosphatidic Acid receptors inhibit platelet activation triggered by the lipid core of atherosclerotic plaques.","volume":"108","author":"Rother","year":"2003","journal-title":"Circulation"},{"key":"R9-20260702","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.atherosclerosis.2013.03.038","article-title":"Increased lysophosphatidic acid levels in culprit coronary arteries of patients with acute coronary syndrome.","volume":"229","author":"Dohi","year":"2013","journal-title":"Atherosclerosis"},{"key":"R10-20260702","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.cmet.2011.02.016","article-title":"Lipoprotein-derived lysophosphatidic acid promotes atherosclerosis by releasing CXCL1 from the endothelium.","volume":"13","author":"Zhou","year":"2011","journal-title":"Cell Metab"},{"key":"R11-20260702","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1093\/eurheartj\/ehac798","article-title":"Long-term outcomes of perioperative myocardial infarction\/injury after non-cardiac surgery.","volume":"44","author":"Puelacher","year":"2023","journal-title":"Eur Heart J"},{"key":"R12-20260702","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s44254-025-00096-4","article-title":"Exploring the association of erythrocytic NO-ferroheme, a surrogate marker of endothelial function with perioperative cardiovascular events in low\/intermediate risk patients undergoing elective non-cardiac surgery.","volume":"3","author":"Boughaleb","year":"2025","journal-title":"Anesthesiol Perioper Sci"},{"key":"R13-20260702","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.3892\/etm.2016.3132","article-title":"Effect of lysophosphatidic acid on the immune inflammatory response and the connexin 43 protein in myocardial infarction.","volume":"11","author":"Zhang","year":"2016","journal-title":"Exp Ther Med"},{"key":"R14-20260702","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.3389\/fphys.2018.01315","article-title":"Lysophosphatidic acid is associated with cardiac dysfunction and hypertrophy by suppressing autophagy via the LPA3\/AKT\/mTOR pathway.","volume":"9","author":"Yang","year":"2018","journal-title":"Front Physiol"},{"key":"R15-20260702","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1161\/CIRCRESAHA.122.321036","article-title":"LPA(2) contributes to vascular endothelium homeostasis and cardiac remodeling after myocardial infarction.","volume":"131","author":"Pei","year":"2022","journal-title":"Circ Res"},{"key":"R16-20260702","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.ymthe.2020.11.004","article-title":"Lysophosphatidic acid receptor 4 is transiently expressed during cardiac differentiation and critical for repair of the damaged heart.","volume":"29","author":"Lee","year":"2021","journal-title":"Mol Ther"},{"key":"R17-20260702","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1038\/s12276-023-01025-w","article-title":"SOX17-mediated LPAR4 expression plays a pivotal role in cardiac development and regeneration after myocardial infarction.","volume":"55","author":"Lee","year":"2023","journal-title":"Exp Mol Med"},{"key":"R18-20260702","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/nchembio.712","article-title":"Lysophosphatidic acid directly activates TRPV1 through a C-terminal binding site.","volume":"8","author":"Nieto-Posadas","year":"2011","journal-title":"Nat Chem Biol"},{"key":"R19-20260702","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1161\/01.CIR.0000142618.20278.7A","article-title":"Sensing tissue ischemia: another new function for capsaicin receptors?","volume":"110","author":"Pan","year":"2004","journal-title":"Circulation"},{"key":"R20-20260702","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1002\/j.2040-4603.2015.tb00616.x","article-title":"Mechanisms of cardiac pain.","volume":"5","author":"Foreman","year":"2015","journal-title":"Compr Physiol"},{"key":"R21-20260702","doi-asserted-by":"crossref","first-page":"44951","DOI":"10.1038\/srep44951","article-title":"Multiple H(+) sensors mediate the extracellular acidification-induced [Ca(2+)]i elevation in cultured rat ventricular cardiomyocytes.","volume":"7","author":"Hu","year":"2017","journal-title":"Sci Rep"},{"key":"R22-20260702","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1080\/19336950.2016.1185579","article-title":"TRPA1 is functionally co-expressed with TRPV1 in cardiac muscle: co-localization at z-discs, costameres and intercalated discs.","volume":"10","author":"Andrei","year":"2016","journal-title":"Channels"},{"key":"R23-20260702","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s00395-023-01031-z","article-title":"Lysophosphatidic acid contributes to myocardial ischemia\/reperfusion injury by activating TRPV1 in spinal cord.","volume":"119","author":"Wu","year":"2024","journal-title":"Basic Res Cardiol"},{"key":"R24-20260702","doi-asserted-by":"crossref","first-page":"e163735","DOI":"10.1172\/JCI163735","article-title":"A human TRPV1 genetic variant within the channel gating domain regulates pain sensitivity in rodents.","volume":"133","author":"He","year":"2023","journal-title":"J Clin Invest"},{"key":"R25-20260702","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.taap.2015.08.007","article-title":"Morphine preconditioning confers cardioprotection in doxorubicin-induced failing rat hearts via ERK\/GSK-3beta pathway independent of PI3K\/Akt.","volume":"288","author":"He","year":"2015","journal-title":"Toxicol Appl Pharmacol"},{"key":"R26-20260702","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.bja.2022.08.040","article-title":"Plasma exosomes generated by ischaemic preconditioning are cardioprotective in a rat heart failure model.","volume":"130","author":"Luo","year":"2023","journal-title":"Br J Anaesth"},{"key":"R27-20260702","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3758\/BF03193146","article-title":"*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences.","volume":"39","author":"Faul","year":"2007","journal-title":"Behav Res Methods"},{"key":"R28-20260702","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.bja.2017.11.110","article-title":"Cardiac mu-opioid receptor contributes to opioid-induced cardioprotection in chronic heart failure.","volume":"121","author":"He","year":"2018","journal-title":"Br J Anaesth"},{"key":"R29-20260702","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s00395-018-0696-8","article-title":"Practical guidelines for rigor and reproducibility in preclinical and clinical studies on cardioprotection.","volume":"113","author":"Botker","year":"2018","journal-title":"Basic Res Cardiol"},{"key":"R30-20260702","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.yjmcc.2011.02.018","article-title":"Retrograde heart perfusion: the Langendorff technique of isolated heart perfusion.","volume":"50","author":"Bell","year":"2011","journal-title":"J Mol Cell Cardiol"},{"key":"R31-20260702","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/nature12822","article-title":"Structure of the TRPV1 ion channel determined by electron cryo-microscopy.","volume":"504","author":"Liao","year":"2013","journal-title":"Nature"},{"key":"R32-20260702","doi-asserted-by":"crossref","first-page":"H1791","DOI":"10.1152\/ajpheart.00169.2007","article-title":"TRPV1 gene knockout impairs preconditioning protection against myocardial injury in isolated perfused hearts in mice.","volume":"293","author":"Zhong","year":"2007","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"R33-20260702","doi-asserted-by":"crossref","first-page":"3617","DOI":"10.1161\/CIRCULATIONAHA.105.556274","article-title":"TRPV1 gene knockout impairs postischemic recovery in isolated perfused heart in mice.","volume":"112","author":"Wang","year":"2005","journal-title":"Circulation"},{"key":"R34-20260702","doi-asserted-by":"crossref","first-page":"e167338","DOI":"10.1172\/JCI167338","article-title":"Striving toward hyperthermia-free analgesia: lessons from loss-of-function mutations of human TRPV1.","volume":"133","author":"Li","year":"2023","journal-title":"J Clin Invest"},{"key":"R35-20260702","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41392-020-00367-5","article-title":"Role of lysophosphatidic acid and its receptors in health and disease: novel therapeutic strategies.","volume":"6","author":"Geraldo","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"R36-20260702","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.bcp.2019.03.035","article-title":"Targeting the autotaxin: lysophosphatidic acid receptor axis in cardiovascular diseases.","volume":"164","author":"Zhao","year":"2019","journal-title":"Biochem Pharmacol"},{"key":"R37-20260702","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3389\/fphys.2017.00153","article-title":"Lysophosphatidic acid pretreatment attenuates myocardial ischemia\/reperfusion injury in the immature hearts of rats.","volume":"8","author":"Chen","year":"2017","journal-title":"Front Physiol"},{"key":"R38-20260702","doi-asserted-by":"crossref","first-page":"356","DOI":"10.3389\/fphys.2017.00356","article-title":"Protective role for LPA3 in cardiac hypertrophy induced by myocardial infarction but not by isoproterenol.","volume":"8","author":"Cai","year":"2017","journal-title":"Front Physiol"},{"key":"R39-20260702","doi-asserted-by":"crossref","first-page":"102884","DOI":"10.1016\/j.ebiom.2020.102884","article-title":"Mitochondria in acute myocardial infarction and cardioprotection.","volume":"57","author":"Ramachandra","year":"2020","journal-title":"EBioMed"},{"key":"R40-20260702","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.atherosclerosis.2012.02.010","article-title":"Lysophosphatidic acid causes endothelial dysfunction in porcine coronary arteries and human coronary artery endothelial cells.","volume":"222","author":"Chen","year":"2012","journal-title":"Atherosclerosis"},{"key":"R41-20260702","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.redox.2017.09.015","article-title":"Cardiac-specific inactivation of LPP3 in mice leads to myocardial dysfunction and heart failure.","volume":"14","author":"Chandra","year":"2018","journal-title":"Redox Biol"},{"key":"R42-20260702","doi-asserted-by":"crossref","first-page":"18362","DOI":"10.3390\/ijms151018362","article-title":"TRPV1 activation exacerbates hypoxia\/reoxygenation-induced apoptosis in H9C2 cells via calcium overload and mitochondrial dysfunction.","volume":"15","author":"Sun","year":"2014","journal-title":"Int J Mol Sci"},{"key":"R43-20260702","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.3390\/cells12182322","article-title":"TRPV1 channels are new players in the Reticulum-Mitochondria Ca(2+) coupling in a rat cardiomyoblast cell line.","volume":"12","author":"Tessier","year":"2023","journal-title":"Cells"},{"key":"R44-20260702","doi-asserted-by":"crossref","first-page":"e003774","DOI":"10.1161\/JAHA.116.003774","article-title":"Transient receptor potential vanilloid 1 regulates mitochondrial membrane potential and myocardial reperfusion injury.","volume":"5","author":"Hurt","year":"2016","journal-title":"J Am Heart Assoc"},{"key":"R45-20260702","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/s41573-021-00268-4","article-title":"Advances in TRP channel drug discovery: from target validation to clinical studies.","volume":"21","author":"Koivisto","year":"2022","journal-title":"Nat Rev Drug Discov"}],"container-title":["Anesthesia &amp; Analgesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1213\/ANE.0000000000007907","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T14:22:29Z","timestamp":1786112549000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1213\/ANE.0000000000007907"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,14]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1213\/ane.0000000000007907","relation":{},"ISSN":["0003-2999","1526-7598"],"issn-type":[{"value":"0003-2999","type":"print"},{"value":"1526-7598","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,14]]}}}